Case for a medical device
Latest Aventis Pharma Deutschland GmbH Patents:
- PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE
- Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
- Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
- 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals
- Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
Description
FIG. 1 is a top plan view of a case for a medical device of our new design;
FIG. 2 is a front view of our new design;
FIG. 3 is an end view of our new design, the opposite end view being a mirror image thereof;
FIG. 4 is a bottom view of our new design;
FIG. 5 is a rear view of our new design; and,
FIG. 6 is a front perspective view of our new design.
Claims
The ornamental design for the case for a medical device, as shown and described.
Referenced Cited
Patent History
Patent number: D480864
Type: Grant
Filed: Sep 9, 2002
Date of Patent: Oct 21, 2003
Assignee: Aventis Pharma Deutschland GmbH (Frankfurt am Main)
Inventors: Stephen Sayers (Buckinghamshire), Miles Hawley (London)
Primary Examiner: Catherine R. Oliver
Attorney, Agent or Law Firm: Finnegan, Henderson, Farabow, Garrett, & Dunner, L.L.P.
Application Number: 29/167,011
Type: Grant
Filed: Sep 9, 2002
Date of Patent: Oct 21, 2003
Assignee: Aventis Pharma Deutschland GmbH (Frankfurt am Main)
Inventors: Stephen Sayers (Buckinghamshire), Miles Hawley (London)
Primary Examiner: Catherine R. Oliver
Attorney, Agent or Law Firm: Finnegan, Henderson, Farabow, Garrett, & Dunner, L.L.P.
Application Number: 29/167,011
Classifications
Current U.S. Class:
D3/203
International Classification: 0301;
International Classification: 0301;